Compounds > yttrium radioisotopes
Page last updated: 2024-08-26

yttrium radioisotopes and Gastrinoma

yttrium radioisotopes has been researched along with Gastrinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R1
Applebaum, L; Barak, D; Eckstein, J; Fraenkel, M; Gross, DJ; Grozinsky-Glasberg, S; Müeller-Brand, J; Shimon, I; Walter, MA1
Bodei, L; Davì, MV; Falconi, M; Ferdeghini, M; Francia, G; Lo Cascio, V; Oliani, C; Paganelli, G; Testoni, M1

Other Studies

3 other study(ies) available for yttrium radioisotopes and Gastrinoma

ArticleYear
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
    The Journal of surgical research, 2011, Volume: 166, Issue:2

    Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes

2011
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas.
    Cancer, 2011, Apr-01, Volume: 117, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Gastrinoma; Humans; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Radioisotopes; Receptors, Peptide; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes

2011
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2008, Volume: 14, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cushing Syndrome; Female; Gastrinoma; Humans; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Yttrium Radioisotopes

2008